Sensory innervation induced by osteoblast-derived netrin-4 attenuates bone loss in aged mice
Ontology highlight
ABSTRACT:
ORGANISM(S): Mus musculus
PROVIDER: GSE317225 | GEO | 2026/01/27
REPOSITORIES: GEO
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| Other | ||||
| GSE317225_WAB_vs_WYB.deseq2.annot.txt.gz | Txt |
Items per page: 5 1 - 2 of 2 |
Similar Datasets
Project description:Sensory innervation induced by osteoblast-derived netrin-4 attenuates bone loss in aged mice
| PRJNA1406306 | ENA
Project description:Low bone mass is strongly associated with multiple neurologic diseases such as Alzheimer’s disease (AD), however it remains unclear if this represents direct specific biologic sequalae of the primary disease process or rather a non-specific finding attributable to alterations in behavior and activity. The recent discovery of skeletal stem cells (SSCs) generating bone forming osteoblasts offers a new opportunity to understand both AD effects on bone and broader neural effects on bone by determining whether there are neural contributions to the SSC niche. Deletion of p75NTR (an essential neurotrophin receptor) was used to probe the contributions of peripheral innervation to the SSC niche. p75NTR deletion either broadly in neurons (p75NTRsyn1 mice) or more specifically in sensory nerves (p75NTRadv mice) but not osteogenic cells (p75NTRocn and p75NTRprx1 mice) or sympathetic nerves (p75NTRth mice), led to decrease in sensory innervation, impaired SSC homeostasis, and bone loss. Consistent with this, pharmacological sensory denervation resulted in a decrease in SSC numbers. More directly, wild-type SSCs transplanted orthotopically into the bones of p75NTRadv host mice with reduced sensory innervation displayed an impaired osteogenic capability, indicating that sensory nerves comprise part of the SSC niche. Decreased sensory innervation in p75NTRadv mice further impaired fracture healing by suppressing SSC expansion. Transcriptomic profiling to identify sensory nerve derived mediators of the SSC niche effect identified that p75NTR regulates expression of Osteopontin (SPP1) in neurons of the dorsal root ganglion (DRG), and SPP1 in turn acts as to promote SSC self-renewal and osteogenic capacity. Lastly, this p75NTR-SPP1 axis is impaired in AD mice, providing a new, direct mechanism for osteopenia in AD both impacting basal bone turnover and fracture repair. Altogether, our findings newly establish sensory nerves as a key component of SSC niche that is disrupted in AD, providing new therapeutic opportunities to augment SSC function to treat bone disorders such as Alzheimer’s associated osteopenia.
2025-08-27 | GSE263602 | GEO
Project description:Sympathetic tone has long been known as a central signaling axis inhibiting osteogenesis. However, the mechanism of this nerve to bone influence remains elusive, especially regarding the specific cellular targets of sympathetic activity. Recently, a bona fide tissue-resident stem cell giving rise to skeletal cell types, skeletal stem cells (SSCs), have been identified. To explore if and how nerves impact SSCs, we utilized mice with conditional deletion of SLIT2, a classic axonal repellent, finding that neural (Slit2syn1 mice) and sympathetic (Slit2th mice) but not bone stem/progenitor (Slit2prx1 mice) or sensory (Slit2adv mice) deletion of Slit2, led to osteopenia due to impaired bone formation associated with an increase in sympathetic innervation and a decrease in the numbers of SSCs. Consistent with this, pharmacological or surgical sympathectomy caused expansion of the SSC pool. More directly, wild type (WT) SSCs transplanted orthotopically into the bones of Slit2th mice with increased sympathetic innervation displayed impaired osteogenic capability, demonstrating that sympathetic nerves functionally contribute to the SSC niche. In line with these findings, the increased sympathetic innervation in Slit2th mice disrupted bone regeneration and bone fracture healing by reducing SSC expansion. Transcriptomic profiling in sympathetic neurons identified Follistatin-like 1 (FSTL1) as a SLIT2-regulated soluble factor that suppressed SSC self-renewal and osteogenic capacity. Accordingly, ablation of Fstl1 in sympathetic neurons enhanced SSC-driven osteogenesis and attenuated the bone loss seen in Slit2th mice in vivo. Altogether, our study both newly establishes SLIT2 as a regulator of skeletal sympathetic innervation and establishes sympathetic nerves as a key component of the SSC niche, providing new therapeutic opportunities to augment SSC function to treat skeletal disorders.
2025-07-28 | GSE284991 | GEO
Project description:Characteristic structural details of the cornea are transparency, the absence of blood vessels, and the presence of numerous sensory nerve endings. The corneal epithelium is one of the most densely innervated tissues of the body. The characteristics of the cornea are established during fetal development, and are lost in adult life when the cornea regenerates after injury. The common reaction of the cornea to injury is the formation of opaque scars, the ingrowth of blood vessels, and distinct changes in the innervation pattern. Scar formation of the cornea is critically modulated by the expression of transforming growth factor-beta (TGF-beta). To identify genes that are important for corneal transparency, dense innervation and absence of blood vessels by comparing corneas from wildtype mice with those that are under the influence of high doses of TGF-beta. Transparency, dense innervation, and absence of blood vessels in the cornea all depend on the expression of a critical set of genes that are not expressed when TGF-beta is present. Mice were generated that overexpress TGF-beta under control of a strong lens-specific promoter. These mice developed opaque corneas that are vascularized and lack sensory nerves. In addition, these corneas were densely populated with cells expressing neural cell adhesion protein. RNA was isolated from corneas of transgenic animals and wildtype littermates in order to analyze differentially expressed genes and to identify those that are only expressed in transparent, avascular, and densely innervated wildtype corneas.
2008-06-15 | E-GEOD-6676 | biostudies-arrayexpress
Project description:Small peripheral neuropathies (SPN) are a common complication in diabetes, affecting around 50% of the diabetic population. Co-occurrence of diabetic peripheral neuropathy (DPN) and diabetic bone disease has led to the hypothesis that DPN influences bone metabolism, although little experimental evidence has yet supported this premise. To investigate, high fat diet (HFD) feeding in mice was performed followed by phenotyping of skeletal-innervating neurons and bone architectural parameters. Results showed that HFD feeding conditions resulted in a marked decrease in skeletal innervation (69-76% reduction in Beta-III-Tubulin-stained nerves, 50-66% reduction in CGRP-stained nerves in long bone periosteum). These changes in skeletal innervation were associated with alterations in bone mass and in cortical and trabecular bone microarchitecture. Single cell RNA-sequencing of sensory neurons and bone tissue was next utilized to reconstruct potential nerve-to-bone signaling interactions, including implication of sensory nerve derived neurotrophins (Bdnf), neuropeptides (Gal, Calca and Calcb) and other morphogens (Vegfa, Pdgfa, and Angpt2). Moreover, scRNA-Seq identified marked shifts in periosteal cell transcriptional changes within HFD fed conditions, including a reduction in proliferation, osteogenic differentiation potency and reductions in WNT, TGFb and MAPK signaling activity. When isolated, periosteal cells from HFD fed mice showed deficits in proliferative and osteogenic differentiation potential. Indeed, these cellular changes in proliferation and differentiation capacity were restored by treatment of HFD exposed periosteal cells to sensory neuron conditioned medium. In sum, HFD modeling of Type 2 diabetes results in a skeletal polyneuropathy. Moreover, the combination of multi-tissue scRNA-Seq and isolated in vitro studies strengthen the case for altered nerve-to-bone signaling in diabetic bone disease.
2025-07-09 | GSE272612 | GEO
Project description:Somatosensory neurons are crucial for detecting a diverse repertoire of stimuli, including in skeletal tissues in which sensations of pain, pressure, and position are transmitted. Trauma to the physis often lead to pathologic "bony bar" formation, impeding normal growth of the skeleton. The role of somatosensory nerves in detecting and in turn regulating such an event is entirely unknown. Here, we observed prominent sensory nerve growth within the injured physis in mouse and human tissues corresponding to domains of NGF expression. Two independent methods to inhibit TrkA (Tropomyosin Receptor Kinase A) signaling significantly reduced nerve sprouting and attenuated pathologic bony bar formation, while converse experiments using neural conditioned medium treated organ cultures showed the opposing effects. Somatosensory nerve retrograde tracing and single cell RNA sequencing (scRNA-Seq) identified the precise neural transcriptome evoked by physis injury. Corresponding scRNA-Seq of injured growth plates implicated PTN neuroregulatory signaling in growth plate pathology. Finally, FDA-approved long acting bupivicaine may be used to prevent pathological innervation and ossification of the growth plate after injury. These findings suggest that targeting somatosensory nerves could offer new strategies to treat pain and optimize patient outcomes after growth plate injury.
2025-12-15 | GSE278355 | GEO
Project description:This study aimed to quantify the regulation of transcripts in the hairy skin of the back of adult rats in the condition of loss of sensory and autonomic (sympathetic) innervation (i.e., denervated). Denervated skin has reduced wound healing capacity, reduced proliferation of epidermal progenitor cells, and also expresses factors that regulate ingrowth of sensory and sympathetic axons from neighboring regions of innervated skin. It was expected that this quantification f transcript regulation would offer insight into the general and specific mechanisms that may contribute to these important biological processes. All animals were adult (200-250g) Sprague-Dawley female rats. Three conditions were examined. Groups were naive (n=6), 7-day denervated skin (n=5), and 14-day (n=5) denervated skin. Denervation preparations: Full-thickness incision along long-axis of the body 1cm to right of midline (to avoid injuring skin to be sampled). Incision was centered rostro-caudally on the T13 (thoracic 13) costo-vertebral angle so as to allow access to the T9-L2 (lumbar 2) cutaneous nerves. Skin was reflected to the left and the left T9, T10, L1, and L2 dorsal and lateral cutaneous nerves were isolated, ligated with 7-0 monofilament suture close to their exit from the body wall, and transected. Approximately 5mm of the distal portion of the nerve was resected. The T11 nerves were left unperturbed and were not isolated from the surrounding fascia. This generated two strips of skin that were devoid of sensory and autonomic innervation (those strips served by the T9 and T10 nerves, and by the L1 and L2 nerves). Between these denervated strips of skin was a strip of skin that retained the sensory and autonomic axons supplied by T11 nerves. The denervated zones were identified by mapping the cutaneous trunk muscle (CTM) reflex (see Petruska-JC et al. (2013) Journal of Comparative Neurology; Diamond-J et al., (1992) J Neuroscience), and the border marked with pen and remarked every few days. The samples were taken from the rostral (T9/10) denervated zone. Samples from naive animals (no denervation) were taken from the same region, using the dorsal cutaneous nerves as registration landmarks. Animals displayed no signs of overgrooming of the denervated skin. Because the CTM inserts onto the dermis of this region of skin, samples necessarily include both skin and underlying CTM (which is innervated from another source so was not denervated in the experiment).
2014-04-08 | E-GEOD-54356 | biostudies-arrayexpress
Project description:Peripheral sensory nerves are thought to contribute to solid tumor growth, particularly in oral squamous cell carcinoma (OSCC); however, the link between pain and immunosuppression remains unresolved. Here, using a prospective observational study, we demonstrate an inverse relationship between OSCC-induced pain mediated by calcitonin gene-related peptide (CGRP)-expressing nerves and tumor-associated immunity. Bulk RNA sequencing of tumor-innervating sensory neurons from mice revealed differential regulation of genes associated with excitability, neurotransmission, and axonal sprouting. Using a gain-of-function approach with persistent stimulation of peptidergic afferents, we show that sensory neurons promote oral tongue tumor growth and limit the activation of effective anti-tumor immune responses via efferent CGRP release. Conversely, loss-of-function approaches—including local ablation of nociceptive nerves and systemic CGRP receptor antagonism—slowed tumor growth and improved anti-tumor immunity. Targeting CGRP may therefore represent a therapeutic strategy in OSCC to reduce pain and improve treatment response.
2026-01-19 | GSE315799 | GEO
Project description:Characteristic structural details of the cornea are transparency, the absence of blood vessels, and the presence of numerous sensory nerve endings. The corneal epithelium is one of the most densely innervated tissues of the body. The characteristics of the cornea are established during fetal development, and are lost in adult life when the cornea regenerates after injury. The common reaction of the cornea to injury is the formation of opaque scars, the ingrowth of blood vessels, and distinct changes in the innervation pattern. Scar formation of the cornea is critically modulated by the expression of transforming growth factor-beta (TGF-beta). To identify genes that are important for corneal transparency, dense innervation and absence of blood vessels by comparing corneas from wildtype mice with those that are under the influence of high doses of TGF-beta. Transparency, dense innervation, and absence of blood vessels in the cornea all depend on the expression of a critical set of genes that are not expressed when TGF-beta is present. Mice were generated that overexpress TGF-beta under control of a strong lens-specific promoter. These mice developed opaque corneas that are vascularized and lack sensory nerves. In addition, these corneas were densely populated with cells expressing neural cell adhesion protein. RNA was isolated from corneas of transgenic animals and wildtype littermates in order to analyze differentially expressed genes and to identify those that are only expressed in transparent, avascular, and densely innervated wildtype corneas. Keywords: TGF-beta overexpression
2007-01-09 | GSE6676 | GEO
Project description:Utilizing surgical and chemical skin sensory denervation methods, we show that afferent neurons support the growth of melanoma tumors in vivo. We demonstrate that sensory innervation limits the activation of effective anti-tumor immune response. Specifically, sensory ablation led to improved leukocyte recruitment and infiltration into tumors, decreased intratumoral lymphoid and myeloid immunosuppressive cells, and the activation of T effector cells within the TME. We found that cutaneous sensory nerves hinder the maturation of intratumoral high endothelial venules and the formation of mature tertriary lymphoid-like structures containing organized clusters of CD4+ T cells and B cells. Denervation further increased T cell clonality and expanded the B cell repertoire in the TME. Importantly, CD8a depletion prevented the denervation-dependent anti-tumor effects. Finally, we observed that the gene signatures associated with immune function and sensory innervation were inversely correlated in human primary cutaneous melanomas, and the latter was a negative prognostic marker of the overall survival in the examined cohort. Our results suggest that tumor-associated sensory neurons negatively regulate the development of effective anti-tumor immune responses, thereby defining a novel target for therapeutic intervention in the cancer setting.
2023-02-20 | GSE193065 | GEO